ExThera Medical Corporation

813 Heinz Avenue
Berkeley, CA 94710 USA
Phone
Fax
Click for website

Research Sector Infectious Disease

Summary Description Develops devices to counter bloodstream infections.

Management Robert S. Ward, Ph.D. - President/CEO; George G. Pitarra, Jr. - Executive Vice President; Keith McCrea, Ph.D. - Chief Technology Officer; Kathleen A. White - Vice President & Chief Operating Officer

Click here for Financial Data
Keywords: blood-borne diseases, bacteremia, sepsis, infection, Seraph, infectious disease, InfectiousDisease

Comment


Updated: Oct. 22, 2015


Description

ExThera Medical Corporation of Berkeley, CA has developed a revolutionary biomimetic medical device that captures and removes a wide range of pathogens and disease-causing agents from circulating bloo......view more

Products / Services

The first clinical application of Seraph will be in the treatment of Staph. aureus (including MRSA) bacteremia in end-stage renal disease patients. Later, Seraph may become a treatment for other bac......view more

Technology / Differentiation

Sepsis is a broadly defined condition that results from the immune system's response to severe infection, leading to cardiovascular collapse and multiple organ failure. It is one of the top-ten causes...view more

Status

Proof-of-concept studies of Seraph, published in peer-reviewed journals, demonstrate that pathogens and inflammatory cytokines are removed in high-yield from human blood. First in Man clinical trial i...view more

RELATED COMPANIES